Volitionrx Limited Revenue per Employee (VNRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Volitionrx Limited  (NYSE: VNRX)
 

Volitionrx Limited's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Volitionrx Limited's Revenue per employee fell on a trailing twelve month basis to $ 32,774, below the company average number of $9,544.
Within the Healthcare sector Employees of 522 other companies have achieved higher revenue per employee. While Volitionrx Limited's total ranking has deteriorated compared to the previous quarter from 3024 to 3578. Volitionrx Limited has 75 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VNRX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -1.97 % 299.81 % 133.25 % 32.19 % 2.75 %
Sales per Employee (TTM) $ 32,774 32,881 23,032 19,627 17,590
VNRX's Total Ranking # 3578 # 3024 # 2839 # 2343 # 2628
Seq. Revenue Change -59.53 % 120.36 % -28.73 % 54.24 % 65.06 %

VNRX Company Profile >> Back to VNRX Efficiency Comparisons >> Compare VNRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 11
Healthcare Sector # 523
Overall Market # 3578

Revenue per Employee Statistics
High Average Low
$ 32,881 $ 9,544 $ 179
(Mar 31 2026)   (Dec 31 2020)



Financial Statements
Volitionrx Limited's Revenue MRQ $ 0 Millions Visit VNRX's Income Statement
Volitionrx Limited's Revenues TTM $ 2 Millions Visit VNRX's aggregate revenue growth
What are VNRX's Sales? Visit VNRX's Sales by Segment




Other Ratios
Volitionrx Limited's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VNRX's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VNRX's Competitors
Revenue per Employee for VNRX's Suppliers
Revenue per Employee for VNRX's Customers

You may also want to know
VNRX's Sales Growth Rates VNRX's Pe Price to earnings ratio VNRX's Receivables Turnover Ratio VNRX's Stock Quote
VNRX's Net Income Growth Rates VNRX's Ps Price to Sales ratio VNRX's Sales per Employee VNRX's Asset Turnover Ratio
VNRX's Net Margin VNRX's Pb Price to Book ratio VNRX's Financial Strength Ratios VNRX's Dividend Payout Ratio
Date modified: 2026-09-03T12:22:38+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Dar Bioscience Inc   56,031.96 $ 1.345  Million 24 
Petvivo Holdings Inc   53,712.00 $ 1.182  Million 22 
Vsee Health Inc   51,479.38 $ 10.759  Million 209 
Tscan Therapeutics Inc   50,077.46 $ 7.111  Million 142 
Cg Oncology Inc   43,859.15 $ 6.228  Million 142 
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Vyne Therapeutics Inc   43,000.00 $ 0.430  Million 10 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Upstream Bio Inc   42,106.67 $ 3.158  Million 75 
Sintx Technologies Inc   41,562.50 $ 1.330  Million 32 
Fate Therapeutics Inc   40,316.77 $ 6.491  Million 161 
Ocugen Inc   39,482.76 $ 4.580  Million 116 
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Entrada Therapeutics Inc   30,828.95 $ 4.686  Million 152 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Seres Therapeutics Inc   28,530.30 $ 1.883  Million 66 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Prime Medicine Inc   27,897.26 $ 4.073  Million 146 
Nexalin Technology Inc   27,144.38 $ 0.217  Million 8 
Bioxcel Therapeutics Inc   25,586.21 $ 0.742  Million 29 
Bioadaptives Inc   25,561.00 $ 0.026  Million 1 
Ataibeckley Inc   22,143.56 $ 4.473  Million 202 
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 
Cardiff Oncology Inc   16,387.10 $ 0.508  Million 31 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.